Sigma Pharmaceuticals bid for API has left a major shareholder furious, while API argues the bid could be superior to the Soul Patts-backed Wesfarmers bid.
API board plays for time afr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from afr.com Daily Mail and Mail on Sunday newspapers.
This story features WESFARMERS LIMITED, and other companies. For more info SHARE ANALYSIS: WES
Wesfarmers has flagged its planned expansion into the personal care, health and well-being sector with a surprise bid for Australian Pharmaceutical Industries
-A strategic acquisition to expand opportunities post the pandemic
-Yet Australian Pharmaceutical has downgraded FY21 guidance
-Will the Wesfarmers bid be a catalyst for the personal care, health sector?
By Eva Brocklehurst
Not content being a hardware, discount department store and office retail conglomerate, Wesfarmers ((WES)) is planning to expand its territory into the personal care, health and well-being sector, seeking growth opportunities post the pandemic.